UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042302
Receipt number R000048295
Scientific Title Efficacy of cocktail analgesic injection to the joint capsule for pain management after total hip arthroplasty
Date of disclosure of the study information 2020/11/02
Last modified on 2022/02/15 22:06:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of cocktail analgesic injection to the joint capsule for pain management after total hip arthroplasty

Acronym

cocktail trial

Scientific Title

Efficacy of cocktail analgesic injection to the joint capsule for pain management after total hip arthroplasty

Scientific Title:Acronym

cocktail trial

Region

Japan


Condition

Condition

osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare postoperative pain on a visual analog scale (VAS) between a group of patients who received a cocktail injection into the joint capsule during total hip arthroplasty and a placebo group.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

pain on a VAS at the end of lumbar spine anesthesia (when lower extremity auto-movement and sensation returned), 6 hours, 12 hours, 24 hours, 3 days, 7 days, at discharge, 4 weeks and 12 weeks post-op.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Triamcinolone acetonide, levobupivacaine

Interventions/Control_2

Betamethasone, levobupivacaine

Interventions/Control_3

saline solution

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

primary total hip arthroplasty

Key exclusion criteria

1) Patients who are difficult to administer lumbar anesthesia
2) Patients requiring total resection of the articular capsule (cases of high dislocation and cases with femoral osteotomy)
3) Patients with poorly controlled diabetic comorbidities and susceptible conditions.
4) Patients with neurological and muscular diseases of the affected limb (e.g., Charcot's joints)
5) Patients with comorbid conditions that may affect consent or assessment, such as dementia, schizophrenia, depression, panic disorder, and generalized anxiety disorder.
6) Patients with a history of allergy to the drugs used in this study.
7) Patients deemed to require lower extremity surgery, including total hip or total knee replacement, within 6 months of participation in this study.
8) Patients who had lower extremity surgery, such as total hip, knee, or osteotomy, in less than 6 months prior to participation in this study.


Translated with www.DeepL.com/Translator (free version)

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Ikemura

Organization

Kyushu University Hospital

Division name

Orthopedic Surgery

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5488

Email

sikemura@ortho.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Ikemura

Organization

Kyushu University Hospital

Division name

Orthopedic Surgery

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5488

Homepage URL


Email

sikemura@ortho.med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu Universit

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyushu University Certified Institutional Review Board for Clinical Trials

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

Tel

092-642-5082

Email

bynintei@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 10 Month 23 Day

Date of IRB

2020 Year 10 Month 23 Day

Anticipated trial start date

2021 Year 01 Month 04 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 10 Month 30 Day

Last modified on

2022 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048295


Research Plan
Registered date File name
2022/02/15 研究計画書 1.5.doc

Research case data specifications
Registered date File name

Research case data
Registered date File name